High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.
High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.
复制标题
DOI:
--
复制
发表时间:
1995-11
期刊:
影响因子:
11.2
通讯作者:
J. Meko;J. Yim;K. Tsung;J. Norton
中科院分区:
文献类型:
--
作者:
J. Meko;J. Yim;K. Tsung;J. Norton
We have constructed a recombinant vaccinia virus (recVV), vKT0334 mIL-12, containing the genes encoding the p35 and p40 subunits of murine interleukin-12 (mIL-12). In vitro experiments demonstrated that vKT0334 mIL-12 efficiently infected a variety of murine and human tumor cell lines and produced very high amounts (1.5 micrograms/10(6) cells/24 h) of biologically active mIL-12. Mice injected s.c. with 10(6) MCA 105 sarcoma cells, followed by injection at the same site with saline or a control recVV, vKT033, containing no mIL-12 genes, all developed progressively growing tumor, whereas 60% of animals injected with vKT0334 mIL-12 remained tumor free (P < 0.0005). Furthermore, tumor growth was significantly reduced in the remaining mice treated with vKT0334 mIL-12 that did develop tumor compared with mice treated with vKT033 (P < 0.03) or saline (P < 0.0001). We conclude that recVV expressing high levels of mIL-12 offers an effective in vivo method of cytokine gene delivery and expression in tumors with subsequent antitumor effect.